State of Wisconsin Investment Board
FENC icon

State of Wisconsin Investment Board’s Fennec Pharmaceuticals FENC Stock Holding History

State of Wisconsin Investment Board’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415K Sell
38,605
-4,895
-11% -$40K ﹤0.01% 2173
2026
Q1 		$268K Sell
43,500
-7,500
-15% -$57.9K ﹤0.01% 2256
2025
Q4 		$393K Buy
51,000
+18,900
+59% +$155K ﹤0.01% 2055
2025
Q3 		$300K Buy
32,100
+8,900
+38% +$77K ﹤0.01% 2105
2025
Q2 		$193K Buy
23,200
+1,200
+5% +$8.21K ﹤0.01% 2201
2025
Q1 		$134K Sell
22,000
-12,000
-35% -$77.1K ﹤0.01% 2150
2024
Q4 		$215K Buy
34,000
+9,600
+39% +$49.2K ﹤0.01% 2123
2024
Q3 		$122K Buy
24,400
+11,366
+87% +$65.8K ﹤0.01% 2199
2024
Q2 		$79.6K Buy
+13,034
New +$108K ﹤0.01% 2231
2019
Q2 		– Sell
-15,600
Closed -$76K – 1559
2019
Q1 		$76K Buy
15,600
+3,600
+30% +$23.7K ﹤0.01% 1517
2018
Q4 		$77K Buy
+12,000
New +$83.9K ﹤0.01% 1509

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State of Wisconsin Investment Board's FENC Position: Q2 2026 in Review

State of Wisconsin Investment Board reduced its Fennec Pharmaceuticals (FENC) stake by 11% in Q2 2026, selling an estimated $40K and leaving 38,605 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #2173.

State of Wisconsin Investment Board first reported a position in FENC in Q4 2018 and has held it in 11 quarters since. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • State of Wisconsin Investment Board held 38,605 shares of Fennec Pharmaceuticals worth $415K as of Q2 2026.
  • State of Wisconsin Investment Board sold 4,895 Fennec Pharmaceuticals shares in Q2 2026, an estimated $40K.
  • Fennec Pharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #2173 holding.
  • State of Wisconsin Investment Board first reported a position in Fennec Pharmaceuticals in Q4 2018 and has held it in 11 quarters since.
  • 104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.